“The Mitigating Role of Transresveratrol Against Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients via Modulating Mitochondrial Gene Expression: A Randomized Controlled Trial”, JOC, vol. 23, no. 1, pp. 751–770, Oct. 2024, doi: 10.64149/J.Carcinog.23.1.751-770.